Human Data Sciences (HDS) has launched a landmark update to the platform that enables researchers to conduct comparative outcomes studies across multiple endpoints simultaneously.
Despite its growing threat to global health, research aimed at tackling antimicrobial resistance (AMR) has been constrained for many years, most likely due to the rapid evolution of resistance in pathogens, regulatory and policy barriers.
Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025.
European Pharmaceutical Manufacturer spoke to Ryan McClymonds, i-team Global's global technical director about cleanroom challenges and how these products help to tackle them.
Verista, a provider of automation, compliance, and quality solutions for the pharmaceutical industry, highlights the LABELQ Label & Print Reconciliation System, a platform engineered to transform label management.
PCI Pharma Services will use the BIO International Convention, 16-19th June in Boston, as a platform to introduce its new purpose-built facility for large-scale sterile fill-finish operations at its campus in nearby Bedford, NH.
As we move further into 2025, it's clear the pharmaceutical manufacturing sector is at a pivotal point. We’re seeing real momentum, in the industry - but also a lot of pressure. Olivia Friett, editor of European Pharmaceutical Manufacturer discusses.
Kivu Bioscience, a biotech company developing next-generation antibody-drug conjugates, has announced a manufacturing partnership with Sterling Pharma Solutions, a global contract development and manufacturing organisation (CDMO).
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has announced an international collaboration with Thermo Fisher Scientific.
Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from July 2025.
